The Global Biosimilars and Biologics Industry is expected to grow at a CAGR of 15.5% during the period 2022-2032. The market is valued at US$ 22,490.62 Mn in 2022 and is expected to reach a valuation of US$ 95,021.37 Mn by 2032. FMI, in its business report, elaborates on the historical and current scenario of the Global …
Tag Archives: Biosimilars And Biologics
North American Biosimilars and Biologics Industry Trends 2022-2032: A Revealing FMI Forecast
North America’s Biosimilars and Biologics Industry Achieves Rapid Growth The market has experienced substantial recent expansion, capturing an impressive 28% share, second only to Europe during the projected period. This growth can be attributed to the continual advancements in healthcare technologies and meticulous drug evaluation procedures, which have significantly boosted the sales of biosimilars and …